These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 29669198)
1. Surface Layer Modification of Poly(d,l-lactic- co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127-Tuftsin Conjugate. Horváti K; Gyulai G; Csámpai A; Rohonczy J; Kiss É; Bősze S Bioconjug Chem; 2018 May; 29(5):1495-1499. PubMed ID: 29669198 [TBL] [Abstract][Full Text] [Related]
2. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles. Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749 [TBL] [Abstract][Full Text] [Related]
3. Nanoparticle encapsulated lipopeptide conjugate of antitubercular drug isoniazid: in vitro intracellular activity and in vivo efficacy in a Guinea pig model of tuberculosis. Horváti K; Bacsa B; Kiss E; Gyulai G; Fodor K; Balka G; Rusvai M; Szabó E; Hudecz F; Bősze S Bioconjug Chem; 2014 Dec; 25(12):2260-8. PubMed ID: 25394206 [TBL] [Abstract][Full Text] [Related]
4. PLGA-LEC/F127 hybrid nanoparticles loaded with curcumin and their modulatory effect on monocytes. T Cruz J; Karen Álvarez ; H Orozco V; Mauricio Rojas ; A Morales-Luckie R; F Giraldo L Nanomedicine (Lond); 2024 Jun; 19(15):1407-1423. PubMed ID: 38920352 [TBL] [Abstract][Full Text] [Related]
5. Matryoshka-type gastro-resistant microparticles for the oral treatment of Mycobacterium tuberculosis. Andreu V; Larrea A; Rodriguez-Fernandez P; Alfaro S; Gracia B; Lucía A; Usón L; Gomez AC; Mendoza G; Lacoma A; Dominguez J; Prat C; Sebastian V; Ainsa JA; Arruebo M Nanomedicine (Lond); 2019 Mar; 14(6):707-726. PubMed ID: 30734643 [TBL] [Abstract][Full Text] [Related]
6. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508 [TBL] [Abstract][Full Text] [Related]
7. Pluronic F127 coating performance on PLGA nanoparticles: Enhanced flocculation and instability. Li M; Tang H; Xiong Y; Yuan Z; He L; Han L Colloids Surf B Biointerfaces; 2023 Jun; 226():113328. PubMed ID: 37156026 [TBL] [Abstract][Full Text] [Related]
8. Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles. Kennedy PJ; Perreira I; Ferreira D; Nestor M; Oliveira C; Granja PL; Sarmento B Eur J Pharm Biopharm; 2018 Jun; 127():366-370. PubMed ID: 29549023 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells. Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365 [TBL] [Abstract][Full Text] [Related]
10. zwitterionic Pluronic analog-coated PLGA nanoparticles for oral insulin delivery. Liu K; Chen Y; Yang Z; Jin J Int J Biol Macromol; 2023 May; 236():123870. PubMed ID: 36870645 [TBL] [Abstract][Full Text] [Related]
12. Controlling ligand surface density optimizes nanoparticle binding to ICAM-1. Fakhari A; Baoum A; Siahaan TJ; Le KB; Berkland C J Pharm Sci; 2011 Mar; 100(3):1045-56. PubMed ID: 20922813 [TBL] [Abstract][Full Text] [Related]
13. Lipids Extracted from Mycobacterial Membrane and Enveloped PLGA Nanoparticles for Encapsulating Antibacterial Drugs Elicit Synergistic Antimicrobial Response against Mycobacteria. Pu X; Wang Y; Wang X; Sang X; Jiang M; Qi D; Zhao X; Chen R; Li J; Liu X; Liu Z; Yang J Mol Pharm; 2024 May; 21(5):2238-2249. PubMed ID: 38622497 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the poly(lactic-co-glycolic acid)/pluronic F127 for injection laryngoplasty in rabbits. Lee JH; Kim DW; Kim EN; Park SW; Kim HB; Oh SH; Kwon SK Otolaryngol Head Neck Surg; 2014 Nov; 151(5):830-5. PubMed ID: 25214547 [TBL] [Abstract][Full Text] [Related]
15. Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity. Carneiro SP; Carvalho KV; de Oliveira Aguiar Soares RD; Carneiro CM; de Andrade MHG; Duarte RS; Dos Santos ODH Colloids Surf B Biointerfaces; 2019 Mar; 175():306-313. PubMed ID: 30553206 [TBL] [Abstract][Full Text] [Related]
16. Preparation of Biodegradable PLGA-Nanoparticles Used for pH-Sensitive Intracellular Delivery of an Anti-inflammatory Bacterial Toxin to Macrophages. Harada A; Tsutsuki H; Zhang T; Lee R; Yahiro K; Sawa T; Niidome T Chem Pharm Bull (Tokyo); 2020; 68(4):363-368. PubMed ID: 32238653 [TBL] [Abstract][Full Text] [Related]
17. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier. Chen YC; Hsieh WY; Lee WF; Zeng DT J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601 [TBL] [Abstract][Full Text] [Related]
18. A functional drug delivery platform for targeting and imaging cancer cells based on Pluronic F127. Zhang D; Tao L; Zhao H; Yuan H; Lan M J Biomater Sci Polym Ed; 2015; 26(8):468-82. PubMed ID: 25780935 [TBL] [Abstract][Full Text] [Related]
19. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies. Khan AM; Ahmad FJ; Panda AK; Talegaonkar S Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254 [TBL] [Abstract][Full Text] [Related]
20. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction. Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]